Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Candropharm is a leading European producer and distributor of high-quality cannabinoid products, specializing in CBD, CBG, and CBN. Based in the Netherlands, the company provides bulk raw materials, including isolates and water-soluble solutions, as well as comprehensive private label and white label services for the global market. Candropharm emphasizes quality assurance through ISO 9001, ISO 22000, and ISO 13485 certifications, ensuring pharmaceutical-grade standards for its hemp-derived extracts. Their product portfolio serves the pharmaceutical, nutraceutical, and cosmetic industries with THC-free and broad-spectrum options. The company is recognized as one of the first European CBD suppliers to implement rigorous safety and quality management systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Candropharm International.